MENU
+Compare
IRMD
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$60.84
Change
+$0.13 (+0.21%)
Capitalization
557.04M

IRMD iRadimed Corp Forecast, Technical & Fundamental Analysis

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them... Show more

IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IRMD with price predictions
Jun 27, 2025

IRMD in upward trend: price rose above 50-day moving average on May 29, 2025

IRMD moved above its 50-day moving average on May 29, 2025 date and that indicates a change from a downward trend to an upward trend. In of 51 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 25, 2025. You may want to consider a long position or call options on IRMD as a result. In of 116 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for IRMD moved above the 200-day moving average on May 29, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 206 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IRMD moved out of overbought territory on June 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for IRMD turned negative on June 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 59 similar instances when the indicator turned negative. In of the 59 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IRMD broke above its upper Bollinger Band on June 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.622) is normal, around the industry mean (24.463). P/E Ratio (31.844) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.004) settles around the average of (0.018) among similar stocks. P/S Ratio (8.340) is also within normal values, averaging (43.062).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IRMD is expected to report earnings to rise 3.57% to 43 cents per share on July 31

iRadimed Corp IRMD Stock Earnings Reports
Q2'25
Est.
$0.44
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.05
The last earnings report on May 05 showed earnings per share of 41 cents, beating the estimate of 40 cents. With 188.75K shares outstanding, the current market capitalization sits at 557.04M.
A.I.Advisor
published Dividends

IRMD paid dividends on May 30, 2025

iRadimed Corp IRMD Stock Dividends
А dividend of $0.17 per share was paid with a record date of May 30, 2025, and an ex-dividend date of May 20, 2025. Read more...
A.I. Advisor
published General Information

General Information

a provider of non-magnetic intravenous infusion pump systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1025 Willa Springs Drive
Phone
+1 407 677-8022
Employees
148
Web
https://www.iradimed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CREAX9.430.04
+0.43%
Columbia Real Estate Equity A
HIGUX20.890.08
+0.38%
Carillon Eagle Growth & Income R6
RRSVX14.660.03
+0.21%
RBC Small Cap Value R6
SSGSX43.860.03
+0.07%
Victory Sycamore Small Company Opp A
PHSTX54.75-0.17
-0.31%
Putnam Global Health Care A

IRMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+0.21%
HBIO - IRMD
53%
Loosely correlated
-9.44%
ICUI - IRMD
44%
Loosely correlated
+0.87%
VREX - IRMD
44%
Loosely correlated
+0.47%
ITGR - IRMD
44%
Loosely correlated
+0.57%
TWST - IRMD
43%
Loosely correlated
-2.73%
More